Annual ROE
-42.10%
-0.43%-1.03%
December 31, 2023
Summary
- As of February 8, 2025, NTLA annual return on equity is -42.10%, with the most recent change of -0.43% (-1.03%) on December 31, 2023.
- During the last 3 years, NTLA annual ROE has fallen by -8.41% (-24.96%).
- NTLA annual ROE is now -172.00% below its all-time high of 58.47%, reached on December 31, 2015.
Performance
NTLA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-51.64%
-2.71%-5.54%
September 30, 2024
Summary
- As of February 8, 2025, NTLA quarterly return on equity is -51.64%, with the most recent change of -2.71% (-5.54%) on September 30, 2024.
- Over the past year, NTLA quarterly ROE has dropped by -8.77% (-20.46%).
- NTLA quarterly ROE is now -169.37% below its all-time high of 74.44%, reached on March 31, 2016.
Performance
NTLA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NTLA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.0% | -20.5% |
| 3 y3 years | -25.0% | -35.6% |
| 5 y5 years | -42.7% | -55.3% |
NTLA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | at low | -43.3% | at low |
| 5 y | 5-year | -25.0% | at low | -43.3% | at low |
| alltime | all time | -172.0% | at low | -169.4% | at low |
Intellia Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -51.64%(+5.5%) |
| Jun 2024 | - | -48.93%(+9.2%) |
| Mar 2024 | - | -44.79%(+4.6%) |
| Dec 2023 | -42.10%(+1.0%) | -42.82%(-0.1%) |
| Sep 2023 | - | -42.87%(-1.0%) |
| Jun 2023 | - | -43.29%(+2.3%) |
| Mar 2023 | - | -42.32%(-11.9%) |
| Dec 2022 | -41.67%(+21.9%) | -48.04%(+4.5%) |
| Sep 2022 | - | -45.98%(+2.8%) |
| Jun 2022 | - | -44.73%(+0.5%) |
| Mar 2022 | - | -44.49%(+23.4%) |
| Dec 2021 | -34.18%(+1.5%) | -36.05%(-5.3%) |
| Sep 2021 | - | -38.08%(-7.4%) |
| Jun 2021 | - | -41.14%(+10.8%) |
| Mar 2021 | - | -37.12%(-4.6%) |
| Dec 2020 | -33.69% | -38.89%(-4.7%) |
| Sep 2020 | - | -40.80%(-0.1%) |
| Jun 2020 | - | -40.83%(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -40.99%(+12.4%) |
| Dec 2019 | -36.34%(+23.2%) | -36.47%(+9.7%) |
| Sep 2019 | - | -33.25%(+1.3%) |
| Jun 2019 | - | -32.82%(+5.5%) |
| Mar 2019 | - | -31.12%(+3.3%) |
| Dec 2018 | -29.50%(+11.5%) | -30.12%(-12.2%) |
| Sep 2018 | - | -34.32%(+2.6%) |
| Jun 2018 | - | -33.46%(+1.7%) |
| Mar 2018 | - | -32.89%(+4.6%) |
| Dec 2017 | -26.46%(-21.1%) | -31.45%(+15.2%) |
| Sep 2017 | - | -27.31%(+22.6%) |
| Jun 2017 | - | -22.27%(-2.3%) |
| Mar 2017 | - | -22.79%(-13.1%) |
| Dec 2016 | -33.54%(-157.4%) | -26.22%(-2.0%) |
| Sep 2016 | - | -26.76%(-28.5%) |
| Jun 2016 | - | -37.41%(-150.3%) |
| Mar 2016 | - | 74.44%(+27.3%) |
| Dec 2015 | 58.47% | 58.47% |
FAQ
- What is Intellia Therapeutics annual return on equity?
- What is the all time high annual ROE for Intellia Therapeutics?
- What is Intellia Therapeutics annual ROE year-on-year change?
- What is Intellia Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly ROE year-on-year change?
What is Intellia Therapeutics annual return on equity?
The current annual ROE of NTLA is -42.10%
What is the all time high annual ROE for Intellia Therapeutics?
Intellia Therapeutics all-time high annual return on equity is 58.47%
What is Intellia Therapeutics annual ROE year-on-year change?
Over the past year, NTLA annual return on equity has changed by -0.43% (-1.03%)
What is Intellia Therapeutics quarterly return on equity?
The current quarterly ROE of NTLA is -51.64%
What is the all time high quarterly ROE for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly return on equity is 74.44%
What is Intellia Therapeutics quarterly ROE year-on-year change?
Over the past year, NTLA quarterly return on equity has changed by -8.77% (-20.46%)